Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Trivedi, M. S., Arber, N., Friedman, E., Garber, J. E., Holcomb, K., Horowitz, N. S., Wright, J. D., Lee, J. J., Vornik, L. A., Abutaseh, S., Castile, T., Sauter, E. R., Dimond, E., Heckman-Stoddard, B. M., House, M., Samimi, G., Brown, P. H., & Crew, K. D. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research, 15(11), 721–726. https://doi.org/10.1158/1940-6207.capr-22-0051
Authors:
Meghna S Trivedi
Nadir Arber
Eitan Friedman
Judy E Garber
Kevin Holcomb
Neil S Horowitz
Jason D Wright
J Jack Lee
Lana A Vornik
Saba Abutaseh
Tawana Castile
Edward R Sauter
Eileen Dimond
Brandy M Heckman-Stoddard
Margaret House
Goli Samimi
Powel H Brown
Katherine D Crew
Affiliated Authors:
Meghna S Trivedi
Jason D Wright
Katherine D Crew
Columbia Affiliation:
Subjects:
Bisphosphonates in Cancer Treatment and Bone Health (OpenAlex Topic)
Molecular Characterization of Colorectal Cancer (OpenAlex Topic)
Hepatitis B Infection and Treatment (OpenAlex Topic)
COVID-19 (MeSH)
Ovarian Neoplasms (MeSH)
Breast Neoplasms (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1158/1940-6207.capr-22-0051
PMID:
36001346
DOI:
10.1158/1940-6207.capr-22-0051
Journal:
Cancer Prevention Research
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: